论文信息 - Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study. - 字舞流文

Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study.

D. Provencher | J. Ledermann | M. Birrer | I. Vergote | S. Pignata | U. Matulonis | J. Sehouli | N. Colombo | P. Ottevanger | G. Sonke | A. Santin | R. Shapira-Frommer | A. Oaknin | S. Keefe | F. Raspagliesi | U. Matulonis | A. Lisyanskaya | A. Lisyanskaya | K. Katchar | J. Ruman | V. Rudaitis | A. González-Martín | H. Wu | G. Sonke | Sandro Pignata | Antonio González-Martín | J. Ledermann | N. Colombo | J. Sehouli | Michael J. Birrer | Diane Provencher | Jane Ruman | S. Pignata